PKBDO3465MWBV
PKBDO3465MWBV
released
Clinical summary
Diabetes status
Type 2 Diabetes
BMI
22
HbA1c %
—
C-Peptide (ng/ml)
—
Diabetes duration
0-5
Demographics
- Age (y)
- 57
- Gender
- Female
- Ethnicity
- White
Additional clinical
- Diabetes (ontology)
- T1D stage
- No sufficient information to derive
- Family history relationship
- -
- Living donor
- No
- Cause of death
- Cerebrovascular/stroke
- Medication
- Oral medications
HLA typing
| Locus | Allele 1 | Allele 2 | Method |
|---|---|---|---|
| A | 2 | — | OPO |
| B | 7 | 13 | OPO |
| C | 06 | 07 | OPO |
| Bw4 | 1 | — | OPO |
| Bw6 | 1 | — | OPO |
| DR | 7 | 103 | OPO |
| DR51 | 0 | — | OPO |
| DR52 | 0 | — | OPO |
| DR53 | 1 | — | OPO |
| DQ | 2 | 5 | OPO |
Supplementary
IIDP
IIDP:SAMN08786195
- Pancreas tissue available
- No
- Other tissues
- —
External resources
IIDP:SAMN08786195
Attribution
Supported by National Institutes of Health (NIH) grants U24 DK138515, U24 DK138512
Supplemental funds from the NIH Office of Data Science Strategies
Supplemental funds from the NIH Office of Data Science Strategies
